BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, May 16, 2026
Home » Topics » Medical technology

Medical technology
Medical technology RSS Feed RSS

Collage of businesspeople

Exactech morphs into Advita Ortho after passing on a 10-year CIA

Nov. 17, 2025
By Mark McCarty
Exactech Inc., of Gainesville, Fla., decided it will not subject itself to a 10-year corporate integrity agreement with the Office of Inspector General, an understandable move given that the company no longer intends to do business in the U.S. under its old brand.
Read More

Appointments and advancements for Nov. 17, 2025

Nov. 17, 2025
New hires and promotions in the med-tech industry, including: Micro Medical Solutions, Onco Nano, Seastar Medical, Tecan Group.
Read More

Financings for Nov. 17, 2025

Nov. 17, 2025
Med-tech firms raising money in public or private financings, including: Veri Medtech.
Read More

In the clinic for Nov. 17, 2025

Nov. 17, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Ocean Dx.
Read More

Other news to note for Nov. 17, 2025

Nov. 17, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Apple, Brainsway, Caranx, Cardiovalve, GE Healthcare, GTCR, ITM, Labcorp, Lunit, Masimo, Naveris, Positron, Surmodics, Venus Medtech.
Read More

Regulatory actions for Nov. 17, 2025

Nov. 17, 2025
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Onward Medical.
Read More

Med-tech gainers and losers for Nov. 10-14, 2025

Nov. 17, 2025
The top 10 med-tech stock gainers and losers for the week.
Read More
Withings Beamo multi-sensor device

FDA clears Withings Beamo, ‘thermometer of the future’

Nov. 14, 2025
By Shani Alexander
Withings SA received U.S. FDA clearance for Beamo, its health check-up tool designed to monitor heart and lung function. Described as the ‘thermometer of the future’, Beamo combines the sensors of an electrocardiogram, a stethoscope and a thermometer into a hand-held device to allow users to check their body temperature, cardiac and pulmonary health in less than a minute.
Read More
Cornerstone Robotics Sentire Surgical System

China’s Cornerstone Robotics raises $200M series D round

Nov. 14, 2025
By Tamra Sami
Cornerstone Robotics Ltd. raised an oversubscribed $200 million series D round to accelerate commercialization of its flagship product, the Sentire Endoscopic Surgical System.
Read More
U.S. EPA building

EPA eases up on PFAS reporting requirements

Nov. 14, 2025
By Mark McCarty
The U.S. Environmental Protection Agency has moved to relax reporting requirements for perfluoroalkyl and polyfluoroalkyl substances used in a variety of applications, including medical devices.
Read More
Previous 1 2 … 59 60 61 62 63 64 65 66 67 … 10247 10248 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 15, 2026.
  • Illustration of a glowing circle to represent circRNA

    ASGCT 2026: Circular RNA, the new beast in gene and cell therapy

    BioWorld
    Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
  • Test tubes, dropper and capsules

    Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal

    BioWorld
    In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 12, 2026
  • 3D illustration of adeno-associated viruses

    ASGCT 2026: Uncovering the mechanisms of AAV toxicity

    BioWorld
    Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing